5 Best Dividend Growth Stocks to Buy and Hold for 3 Years

Page 5 of 5

1. The Cigna Group (NYSE:CI)

5-Dividend Growth Rate: 42.40%

On May 22, UBS raised its price recommendation on The Cigna Group (NYSE:CI) to $400 from $375. It reiterated a Buy rating on the shares. The analyst said managed care organizations broadly increased guidance after stronger-than-expected Q1 results. Favorable respiratory trends and seasonal cost patterns helped support performance during the quarter. The analyst also noted that improved Medicare Advantage rates, steadier ACA exchange enrollment, and modest Medicaid outperformance strengthened confidence in margin recovery. At the same time, the sector continues to deal with cost pressures tied to specialty drugs, GLP-1 treatments, and behavioral health expenses, according to the research note.

On May 20, Morgan Stanley raised its price goal on CI to $361 from $355. It kept an Overweight rating on the stock. The firm made the change after meetings with management that, in its view, “reinforced the underappreciated” specialty opportunity. The analyst added that the company’s September investor day is expected to highlight its growing long-term focus on Specialty businesses.

The Cigna Group (NYSE:CI) operates as a global health company with two business segments: Evernorth Health Services and Cigna Healthcare.

While we acknowledge the potential of CI to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than CI and that has 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 10 High Quality Stocks to Buy According to Hedge Funds and 10 Best Long Term Low Risk Stocks to Buy According to Hedge Funds

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 5 of 5
1281292 - 11759070 - 1